• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性癌症筛查。

Cancer Screening in Women.

机构信息

Department of Obstetrics and Gynecology # 22, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.

Department of Obstetrics and Gynecology # 22, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.

出版信息

Obstet Gynecol Clin North Am. 2019 Sep;46(3):485-499. doi: 10.1016/j.ogc.2019.04.007.

DOI:10.1016/j.ogc.2019.04.007
PMID:31378290
Abstract

Advancements in cancer screening techniques have allowed for earlier detection of cancer at premalignant or early stages of disease. Several organizations have guidelines for screening strategies for breast, cervical, colon, and lung cancer. Ovarian cancer remains the deadliest cancer of the female reproductive tract; however, guidelines have yet to be shown effective in identifying ovarian cancer at earlier stages. It is important that providers familiarize themselves with up-to-date screening strategies in women at average risk and at increased risk of disease. The provider's role in guiding patients toward screening programs and counseling regarding risk reduction is one of the most important.

摘要

癌症筛查技术的进步使得能够在癌前病变或疾病早期阶段更早地发现癌症。一些组织制定了乳腺癌、宫颈癌、结肠癌和肺癌筛查策略的指南。卵巢癌仍然是女性生殖道最致命的癌症;然而,这些指南在更早阶段识别卵巢癌方面尚未被证明有效。了解处于平均风险和疾病风险增加的女性的最新筛查策略对提供者来说非常重要。提供者在指导患者进行筛查计划和咨询风险降低方面的作用是最重要的之一。

相似文献

1
Cancer Screening in Women.女性癌症筛查。
Obstet Gynecol Clin North Am. 2019 Sep;46(3):485-499. doi: 10.1016/j.ogc.2019.04.007.
2
ACS releases updated guidelines on cancer screening.美国临床肿瘤学会发布癌症筛查更新指南。
Am Fam Physician. 2012 Sep 15;86(6):571, 576-7.
3
Summaries for Patients. Screening for cancer.患者摘要。癌症筛查。
Ann Intern Med. 2015 May 19;162(10). doi: 10.7326/P15-9020.
4
Cancer screening of older women : a primary care issue.老年女性的癌症筛查:一个初级保健问题。
Cancer Pract. 1998 Jul-Aug;6(4):217-22. doi: 10.1046/j.1523-5394.1998.006004217.x.
5
Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.基层医疗环境中的癌症筛查:基层医疗医生在乳腺癌、宫颈癌、结直肠癌、肺癌、卵巢癌和前列腺癌筛查中的作用。
Prim Care. 2007 Mar;34(1):137-67. doi: 10.1016/j.pop.2007.02.002.
6
Screening for breast and cervical cancer: understanding the different recommendations.乳腺癌和宫颈癌筛查:了解不同的建议。
Nurs Womens Health. 2013 Aug-Sep;17(4):331-5. doi: 10.1111/1751-486X.12052.
7
Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey.5 个欧洲国家女性对女性癌症预测性表观遗传学风险检测的认知、态度和预期行为:一项跨欧洲国家的在线横断面调查。
BMC Public Health. 2019 May 30;19(1):667. doi: 10.1186/s12889-019-6994-8.
8
The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.健康保险作为癌症筛查决定因素的重要性:来自女性健康倡议的证据。
Prev Med. 2000 Sep;31(3):261-70. doi: 10.1006/pmed.2000.0697.
9
An Update on Screening and Prevention for Breast and Gynecological Cancers in Average and High Risk Individuals.一般风险和高风险个体的乳腺癌和妇科癌症筛查与预防更新。
Am J Med Sci. 2020 Nov;360(5):489-510. doi: 10.1016/j.amjms.2020.06.008. Epub 2020 Jun 10.
10
Implementing recommendations for the early detection of breast and cervical cancer among low-income women.落实针对低收入女性乳腺癌和宫颈癌早期检测的建议。
MMWR Recomm Rep. 2000 Mar 31;49(RR-2):37-55.

引用本文的文献

1
The Roles of Autophagy-related miRNAs in Gynecologic Tumors: A Review of Current Knowledge for Possible Targeted Therapy.自噬相关 miRNA 在妇科肿瘤中的作用:靶向治疗的相关知识综述
Curr Mol Med. 2024;24(10):1269-1281. doi: 10.2174/0115665240263059231002093454.
2
DNA Methylation of a Group of Long Non-Coding RNA Genes at Different Stages of Ovarian Cancer Dissemination.卵巢癌转移不同阶段一组长链非编码 RNA 基因的 DNA 甲基化。
Bull Exp Biol Med. 2024 Feb;176(4):495-500. doi: 10.1007/s10517-024-06054-7. Epub 2024 Mar 16.
3
Matrine Targets BTF3 to Inhibit the Growth of Canine Mammary Tumor Cells.
苦参碱靶向 BTF3 抑制犬乳腺肿瘤细胞生长。
Int J Mol Sci. 2023 Dec 30;25(1):540. doi: 10.3390/ijms25010540.
4
Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.20 个 miRNA 基因在卵巢癌扩散的各个步骤中的异常甲基化:从原发性肿瘤到腹膜宏观转移。
Int J Mol Sci. 2022 Jan 24;23(3):1300. doi: 10.3390/ijms23031300.
5
LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.长链非编码 RNA MALAT1 通过促进肿瘤微环境中的化疗耐药性和侵袭性促进卵巢癌进展。
Int J Mol Sci. 2021 Sep 22;22(19):10201. doi: 10.3390/ijms221910201.
6
Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect.卵巢肿瘤及其转移中新长非编码 RNA 基因的超甲基化:双重效应。
Bull Exp Biol Med. 2021 Jul;171(3):370-374. doi: 10.1007/s10517-021-05230-3. Epub 2021 Jul 22.
7
LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.长链非编码 RNA 在卵巢癌进展、转移及主要通路中的作用: ceRNA 和替代机制
Int J Mol Sci. 2020 Nov 23;21(22):8855. doi: 10.3390/ijms21228855.
8
Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer.鉴定 miR-200 家族成员作为人类和产蛋鸡卵巢癌的血液生物标志物。
Sci Rep. 2020 Nov 18;10(1):20071. doi: 10.1038/s41598-020-77068-0.
9
Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses.血清 miR-125b 水平与上皮性卵巢癌(EOC)的发生发展及治疗反应相关。
Bioengineered. 2020 Dec;11(1):311-317. doi: 10.1080/21655979.2020.1736755.